Dermatology Imaging Devices Market Summary

The global dermatology imaging devices market was valued at USD 2.42 billion in 2023 and is expected to expand to USD 5.60 billion by 2030, registering a CAGR of 13.09% from 2024 to 2030. Market growth is primarily supported by the rising prevalence of skin disorders, increasing awareness related to skin cancer detection, and growing demand for non-invasive diagnostic techniques. These factors are encouraging healthcare providers to adopt advanced imaging technologies for early and accurate diagnosis.

Continuous technological innovation has led to the development of highly advanced dermatology imaging devices that offer improved accuracy and faster diagnostic outcomes. The adoption of technologies such as optical coherence tomography (OCT) and confocal microscopy has significantly enhanced the ability to visualize skin layers in high resolution without invasive procedures. These advancements have transformed clinical dermatology by enabling precise evaluation of skin conditions while minimizing patient discomfort.

The escalating global incidence of skin cancer is a key factor driving demand for dermatology imaging devices. According to the American Academy of Dermatology Association, skin cancer is highly prevalent in the United States, with approximately 9,500 new diagnoses daily, and over 1 million individuals currently living with melanoma. Estimates indicate that around 197,700 new melanoma cases were expected in 2022, with 97,920 cases diagnosed using non-invasive methods and 99,780 cases identified through invasive procedures. While skin cancer is more common among women under the age of 50, its incidence is notably higher among men over 50, largely due to differences in occupational and recreational exposure to ultraviolet radiation.

Further statistics show that approximately 1 in 27 men and 1 in 40 women are projected to develop melanoma during their lifetime. Although melanoma accounts for only 1% of all skin cancers in the U.S., it is responsible for the majority of skin cancer-related deaths. According to the American Society of Clinical Oncology (ASCO), an estimated 7,990 melanoma-related deaths were expected in the U.S. in 2023, including 5,420 men and 2,570 women. These alarming figures highlight the critical importance of early detection and reinforce the demand for advanced dermatology imaging solutions.

Order a free sample PDF of the Dermatology Imaging Devices Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

  • North America dominated the dermatology imaging devices market with a 39.48% revenue share in 2023.
  • The U.S. dermatology imaging devices market is expected to grow at the fastest CAGR over the forecast period.
  • By end use, the hospitals segment accounted for the largest revenue share of 43.99% in 2023.
  • By modality, the dermatoscope segment led the market with a 41.42% revenue share in 2023.
  • By application, the skin cancer segment held the largest revenue share of 48.63% in 2023.

Market Size & Forecast

  • 2023 Market Size: USD 2.42 Billion
  • 2030 Projected Market Size: USD 5.60 Billion
  • CAGR (2024–2030): 13.09%
  • Largest Market (2023): North America
  • Fastest Growing Market: Asia Pacific

Key Dermatology Imaging Devices Company Insights

Leading companies operating in the dermatology imaging devices market include GE HealthCare, VisualSonics, Koninklijke Philips N.V., Canfield Scientific, Inc., FotoFinder Systems GmbH, and e-con Systems Inc. These organizations are actively enhancing their product portfolios through technological upgrades, strategic collaborations, and mergers and acquisitions. In addition, several emerging players such as Metaoptima, DermLite, DermaSensor, Courage+Khazaka electronic GmbH, Longport, Inc., Cortex Technology, DRAMI艃SKI S. A., Clarius, Michelson Diagnostics Ltd (MDL), and Caliber Imaging and Diagnosis are contributing to innovation and intensifying competition in the market.

Key Dermatology Imaging Devices Companies

  • Canfield Scientific, Inc.
  • FotoFinder Systems GmbH
  • e-con Systems Inc.
  • Courage+Khazaka electronic GmbH
  • Longport, Inc.
  • Cortex Technology
  • DRAMI艃SKI S. A.
  • GE HealthCare
  • VisualSonics
  • Clarius
  • Koninklijke Philips N.V.
  • Michelson Diagnostics Ltd (MDL)
  • Caliber Imaging and Diagnosis
  • DermLite

Explore Horizon Databook - The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The dermatology imaging devices market is poised for strong growth through 2030, driven by rising skin disease prevalence, increasing skin cancer awareness, and rapid advancements in non-invasive imaging technologies. The integration of high-resolution imaging tools such as OCT and confocal microscopy is transforming dermatological diagnostics by enabling early and accurate disease detection. With growing investments from established players and the entry of innovative emerging companies, the market is expected to witness sustained expansion, particularly across rapidly developing regions such as Asia Pacific.